These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33472449)

  • 1. Progress and new horizons toward a VAR2CSA-based placental malaria vaccine.
    Doritchamou JYA; Suurbaar J; Tuikue Ndam N
    Expert Rev Vaccines; 2021 Feb; 20(2):215-226. PubMed ID: 33472449
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress and Insights Toward an Effective Placental Malaria Vaccine.
    Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA
    Front Immunol; 2021; 12():634508. PubMed ID: 33717176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.
    Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE
    Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development.
    Benavente ED; Oresegun DR; de Sessions PF; Walker EM; Roper C; Dombrowski JG; de Souza RM; Marinho CRF; Sutherland CJ; Hibberd ML; Mohareb F; Baker DA; Clark TG; Campino S
    Sci Rep; 2018 Oct; 8(1):15429. PubMed ID: 30337594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
    Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
    Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC.
    Chêne A; Gangnard S; Guadall A; Ginisty H; Leroy O; Havelange N; Viebig NK; Gamain B
    EBioMedicine; 2019 Apr; 42():145-156. PubMed ID: 30885725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
    PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine.
    Gill J; Chakraborti S; Bharti P; Sharma A
    Int J Infect Dis; 2021 Nov; 112():35-39. PubMed ID: 34450283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
    Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
    J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
    Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
    Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a vaccine against pregnancy-associated malaria.
    Tuikue Ndam N; Deloron P
    Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroporation-mediated genetic vaccination for antigen mapping: application to Plasmodium falciparum VAR2CSA protein.
    Bordbar B; Gnidehou S; Ndam NT; Doritchamou J; Moussiliou A; Quiviger M; Deloron P; Scherman D; Bigey P
    Bioelectrochemistry; 2012 Oct; 87():132-7. PubMed ID: 22265101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing vaccines to prevent malaria in pregnant women.
    Tuikue-Ndam N; Deloron P
    Expert Opin Biol Ther; 2015; 15(8):1173-82. PubMed ID: 26051589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris.
    Avril M; Hathaway MJ; Cartwright MM; Gose SO; Narum DL; Smith JD
    Malar J; 2009 Jun; 8():143. PubMed ID: 19563628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VAR2CSA-Mediated Host Defense Evasion of
    Tomlinson A; Semblat JP; Gamain B; Chêne A
    Front Immunol; 2020; 11():624126. PubMed ID: 33633743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity.
    Renn JP; Doritchamou JYA; Tentokam BCN; Morrison RD; Cowles MV; Burkhardt M; Ma R; Mahamar A; Attaher O; Diarra BS; Traore M; Dicko A; Tolia NH; Fried M; Duffy PE
    Commun Biol; 2021 Nov; 4(1):1309. PubMed ID: 34799664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.